Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4553496

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1nc(C(=O)NC2CCN(C)CC2)c(C)c(-c2ccc(Cl)cc2)c1[C@H](OC(C)(C)C)C(=O)O

Basic Information

ChEMBL ID CHEMBL4553496
Phase Preclinical
Structure Type MOL
InChI Key XFTOGQGXUKOMHA-QHCPKHFHSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

488.0
MW (Da)
4.78
ALogP
5
HBA
2
HBD
91.8
PSA (Ų)
0.61
QED
0
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C26H34ClN3O4
MW 488.03
Aromatic Rings 2
Heavy Atoms 34
NP-Likeness -0.62

Activity Summary

EC50 1 meas. best 5.66

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
EC50 5.66 5.66 2200.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked EC50 = 2200.0 nM 5.66 Inhibition of HIV NL4.3 integrase T124/T125 double mutant assessed as reduction ... 27563405

Literature References

PubMed DOI Target Context # Activities
27563405 10.1021/acsmedchemlett.6b00194 Unchecked 1

Data from ChEMBL 36 via Core Engine